| Viral quasispecies evolution E Domingo, J Sheldon, C Perales Microbiology and Molecular Biology Reviews 76 (2), 159-216, 2012 | 1146 | 2012 |
| Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir J Sheldon, N Camino, B Rodés, A Bartholomeusz, M Kuiper, F Tacke, ... Antiviral therapy 10 (6), 727-734, 2005 | 412 | 2005 |
| Prevalence and transmission of Kaposi's sarcoma‐associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents S Mayama, LE Cuevas, J Sheldon, OH Omar, DH Smith, P Okong, B Silvel, ... International journal of cancer 77 (6), 817-820, 1998 | 322 | 1998 |
| Bone marrow failure associated with human herpesvirus 8 infection after transplantation M Luppi, P Barozzi, TF Schulz, G Setti, K Staskus, R Trovato, F Narni, ... New England Journal of Medicine 343 (19), 1378-1385, 2000 | 271 | 2000 |
| Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy. ML Calabro, J Sheldon, A Favero, GR Simpson, JR Fiore, E Gomes, ... Journal of Human Virology 1 (3), 207-213, 1998 | 201 | 1998 |
| Hepatitis B virus escape mutants induced by antiviral therapy J Sheldon, V Soriano Journal of antimicrobial chemotherapy 61 (4), 766-768, 2008 | 186 | 2008 |
| Mutations affecting the replication capacity of the hepatitis B virus J Sheldon, B Rodes, F Zoulim, A Bartholomeusz, V Soriano Journal of viral hepatitis 13 (7), 427-434, 2006 | 184 | 2006 |
| The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen–positive and hepatitis B e antigen–negative hepatitis B virus … S Amini‐Bavil‐Olyaee, U Herbers, J Sheldon, T Luedde, C Trautwein, ... Hepatology 49 (4), 1158-1165, 2009 | 181 | 2009 |
| Mother-to-child transmission of human herpesvirus-8 in South Africa M Dedicoat, R Newton, KR Alkharsah, J Sheldon, I Szabados, B Ndlovu, ... The Journal of infectious diseases 190 (6), 1068-1075, 2004 | 178 | 2004 |
| HUMAN HERPES VIRUS-8 AND OTHER RISK FACTORS FOR KAPOSI'S SARCOMA IN KIDNEY TRANSPLANT RECIPIENTS1 D Farge, C Lebbé, Z Marjanovic, P Tuppin, C Mouquet, MN Peraldi, ... Transplantation 67 (9), 1236-1242, 1999 | 166 | 1999 |
| Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple … A Viejo-Borbolla, M Ottinger, E Brüning, A Bürger, R König, E Kati, ... Journal of virology 79 (21), 13618-13629, 2005 | 141 | 2005 |
| Transient angiolymphoid hyperplasia and Kaposi's sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection E Oksenhendler, D Cazals-Hatem, TF Schulz, V Barateau, L Grollet, ... New England Journal of Medicine 338 (22), 1585-1590, 1998 | 135 | 1998 |
| Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients? J Sheldon, B Ramos, C Toro, P Ríos, J Martínez-Alarcón, M Bottecchia, ... Antiviral therapy 13 (1), 97-102, 2008 | 129 | 2008 |
| High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods J Quer, J Gregori, F Rodríguez-Frias, M Buti, A Madejon, ... Journal of clinical microbiology 53 (1), 219-226, 2015 | 110 | 2015 |
| Risk factors for human herpesvirus 8 infection and AIDS‐associated Kaposi's sarcoma among men who have sex with men in a European multicentre study E Martró, A Esteve, TF Schulz, J Sheldon, G Gambús, R Munoz, D Whitby, ... International journal of cancer 120 (5), 1129-1135, 2007 | 108 | 2007 |
| HHV-8 and multiple myeloma in the UK J MacKenzie, J Sheldon, G Morgan, G Cook, TF Schulz, RF Jarrett The Lancet 350 (9085), 1144-1145, 1997 | 106 | 1997 |
| Two distinct gamma-2 herpesviruses in African green monkeys: a second gamma-2 herpesvirus lineage among old world primates? J Greensill, JA Sheldon, NM Renwick, BE Beer, S Norley, J Goudsmit, ... Journal of virology 74 (3), 1572-1577, 2000 | 103 | 2000 |
| Susceptibility to protease inhibitors in HIV-2 primary isolates from patients failing antiretroviral therapy B Rodés, J Sheldon, C Toro, V Jiménez, MA Alvarez, V Soriano Journal of antimicrobial chemotherapy 57 (4), 709-713, 2006 | 102 | 2006 |
| Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection G Schmutz, M Nelson, T Lutz, J Sheldon, R Bruno, F von Boemmel, ... Aids 20 (15), 1951-1954, 2006 | 100 | 2006 |
| Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virus J Sheldon, NM Beach, E Moreno, I Gallego, D Piñeiro, E Martínez-Salas, ... Journal of virology 88 (20), 12098-12111, 2014 | 91 | 2014 |
